Lemiale F - Search Results

1

Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolates and their relationship to immunogenicity.

Brand D, Lemiale F, Thibault G, Verrier B, Lebigot S, Roingeard P, Buzelay L, Brunet S, Barin F. Brand D, et al. Among authors: lemiale f. Virology. 2000 Jun 5;271(2):350-62. doi: 10.1006/viro.2000.0322. Virology. 2000. PMID: 10860888 Free article.

2

Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles.

Brand D, Lemiale F, Turbica I, Buzelay L, Brunet S, Barin F. Brand D, et al. Among authors: lemiale f. AIDS Res Hum Retroviruses. 1998 Oct 10;14(15):1369-77. doi: 10.1089/aid.1998.14.1369. AIDS Res Hum Retroviruses. 1998. PMID: 9788678

3

Identification of the glycoprotein 41(TM) cytoplasmic tail domains of human immunodeficiency virus type 1 that interact with Pr55Gag particles.

Hourioux C, Brand D, Sizaret PY, Lemiale F, Lebigot S, Barin F, Roingeard P. Hourioux C, et al. Among authors: lemiale f. AIDS Res Hum Retroviruses. 2000 Aug 10;16(12):1141-7. doi: 10.1089/088922200414983. AIDS Res Hum Retroviruses. 2000. PMID: 10954889

4

Immunogenicity of recombinant envelope glycoproteins derived from T-cell line-adapted isolates or primary HIV isolates: a comparative study using multivalent vaccine approaches.

Lemiale F, Brand D, Lebigot S, Verrier B, Buzelay L, Brunet S, Barin F. Lemiale F, et al. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):413-22. doi: 10.1097/00126334-200104150-00003. J Acquir Immune Defic Syndr. 2001. PMID: 11391160

5

The transmembrane protein of HIV-1 primary isolates modulates cell surface expression of their envelope glycoproteins.

Lebigot S, Roingeard P, Thibault G, Lemiale F, Verrier B, Barin F, Brand D. Lebigot S, et al. Among authors: lemiale f. Virology. 2001 Nov 10;290(1):136-42. doi: 10.1006/viro.2001.1177. Virology. 2001. PMID: 11882998 Free article.

6

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Lemiale F, Kong WP, Akyürek LM, Ling X, Huang Y, Chakrabarti BK, Eckhaus M, Nabel GJ. Lemiale F, et al. J Virol. 2003 Sep;77(18):10078-87. doi: 10.1128/jvi.77.18.10078-10087.2003. J Virol. 2003. PMID: 12941918 Free PMC article.

7

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

Lemiale F, Haddada H, Nabel GJ, Brough DE, King CR, Gall JG. Lemiale F, et al. Vaccine. 2007 Mar 1;25(11):2074-84. doi: 10.1016/j.vaccine.2006.11.025. Epub 2006 Nov 28. Vaccine. 2007. PMID: 17250935 Free PMC article.

8

An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.

Lemiale F, Asefa B, Ye D, Chen C, Korokhov N, Humeau L. Lemiale F, et al. Vaccine. 2010 Feb 23;28(8):1952-61. doi: 10.1016/j.vaccine.2009.10.089. Vaccine. 2010. PMID: 20188251

9

Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity.

Asefa B, Korokhov N, Lemiale F. Asefa B, et al. Among authors: lemiale f. Vaccine. 2010 Apr 30;28(20):3617-24. doi: 10.1016/j.vaccine.2009.12.047. Epub 2010 Jan 4. Vaccine. 2010. PMID: 20051277

10

Lentiviral vectors for HIV disease prevention and treatment.

Lemiale F, Korokhov N. Lemiale F, et al. Vaccine. 2009 May 26;27(25-26):3443-9. doi: 10.1016/j.vaccine.2009.01.055. Epub 2009 Feb 6. Vaccine. 2009. PMID: 19201386 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters